Health Sciences Research Awards and Grants
* Award dollars are not included in the clinical trials, as funds are earned based upon completion of study milestones and enrollment.
| Title | Type | $ Amount | Activity | Investigator | Unit | Sponsor | Date |
|---|---|---|---|---|---|---|---|
| STORM-PE: A Prospective, Multicenter, Randomized Controlled Trial Evaluating Anticoagulation Alone vs Anticoagulation plus Mechanical Aspiration with the Indigo Aspiration System for the Treatment of | Contract | * | Clinical Trial | Gregory Woodhead | Medical Imaging | Penumbra Incorporated | 04/2024 |
| Targeting Cardiac Fibroblast Activation, a Cross-Border Collaboration | Grant | 10,000.00 | Research | Taben Hale | COM Phx Basic Medical Sci | American Heart Association, Incorporated | 04/2024 |
| Targeting p53-mutated head and neck squamous cell carcinoma. | Grant | 749,993.00 | Research | Carlos Caulin | Otolaryngology | Arizona Biomedical Research Centre | 04/2024 |
| The Mind and Appetite After Midnight | Grant | 4,320.00 | Research | Kathryn Kennedy | Psychiatry | Sleep Research Society | 04/2024 |
| The Role of Hdac9 Activation in the Pathogenesis of E-Cigarette-Induced Atherosclerosis by Promoting Endothelial-Mesenchymal Transition | Grant | 225,000.00 | Research | Chen-wei Liu | COM Phx Basic Medical Sci | Arizona Biomedical Research Centre | 04/2024 |
| The Role of Na+/H+ Exchange in Shaping Gut Microbial-Epithelial Interactions and Susceptibility to Enteric Infection During Postnatal Development | Grant | 224,991.00 | Research | Claudio Bernardazzi de Miranda Azevedo | Pediatrics | Arizona Biomedical Research Centre | 04/2024 |
| The Role of S-Glutathione in Regulating Cardiac Myosin Binding Protein-C Function | Grant | 210,372.00 | Research Training | Angela Greenman | Cellular & Molecular Medicine | National Heart, Lung, and Blood Institute | 04/2024 |
| University of Arizona Prevention Mobile Health Unit | Cooperative Agreement | 102,783.00 | Other Sponsored Activity | Sheila Soto | Public Hlth Prac & Trans Rsch | Arizona Department of Health Services | 04/2024 |
| VA IPA for Iyengar | Contract | 49,999.00 | Research | Michael Fallon | COM Phx Internal Medicine | United States Department of Veterans Affairs | 04/2024 |
| 1/2 - Pediatric Prehospital Airway Resuscitation Trial | Cooperative Agreement | 116,052.00 | Research | Joshua Gaither | Dept of Emergency Medicine | Ohio State University | 03/2024 |
| 1/2 Trauma Resuscitation with Group O Whole Blood Or Products (TROOP) Trial | Cooperative Agreement | 267,876.00 | Research | Bellal Joseph | Surgery | University of Alabama at Birmingham | 03/2024 |
| A Phase 1b Study of the OxPhos Inhibitor ME-344 Combined With Bevacizumab in Previously Treated Metastatic Colorectal Cancer | Contract | * | Clinical Trial | Aaron Scott | Cancer Center Division | MEI Pharma, Inc. | 03/2024 |
| A Phase 2b, Multinational, Randomized, Double-blind Study to Investigate the Efficacy and Safety of Redasemtide (S-005151) Compared With Placebo in Adult Participants With Acute Ischemic Stroke Who Ar | Contract | * | Clinical Trial | Firas Kaddouh | Neurology | PPD Investigator Services, LLC. | 03/2024 |
| A Randomized Phase 2 Non-inferiority Trial of (Z)-endoxifen and Exemestane + Goserelin as Neoadjuvant Treatment in Premenopausal Women with ER+/HER2- Breast Cancer | Contract | * | Clinical Trial | Sima Ehsani Chimeh | Cancer Center Division | Atossa Therapeutics | 03/2024 |
| A Randomized, Double-Blind, Dose-Ranging, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Pln-74809 (Bexotegrast) for the Treatment of Idiopathic Pulmonary Fibrosis (BEACON-IPF) | Contract | * | Clinical Trial | Sachin Chaudhary | Medicine | Pliant Therapeutics, Inc. | 03/2024 |
| A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Delay of Encephalopathy Decompensation i | Contract | * | Clinical Trial | Moises Nevah Rubin | COM Phx Internal Medicine | Salix Pharmaceuticals, Incorporated | 03/2024 |
| A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Investigate the Safety and Efficacy of KER-012 in Combination with Background Therapy in Adult Participants with Pulmonary Arterial Hyp | Contract | * | Clinical Trial | Franz Rischard | Medicine | IQVIA RDS Inc. | 03/2024 |
| An Open-label, Controlled, Randomized Phase 3 Trial Evaluating 12-month Kidney Function in Highly Sensitized (cPRA > 99.9%) Kidney Transplant Patients With Positive Crossmatch Against a Deceased Donor | Contract | * | Clinical Trial | Kenneth Bodziak | COM Phx Internal Medicine | CTI Clinical Trial and Consulting Services Incorporated | 03/2024 |
| Animal Purchasing and Husbandry Service Agreement in support of Protocol#15-598 "The Role of the Periaqueductal Gray in Mediating Traumatic Brain Injury Induced Thermal and Mechanical Hypersensitivity | Contract | 28,780.75 | Research | Mohab Ibrahim | Anesthesiology | United States Department of Veterans Affairs | 03/2024 |
| Assessing Variation in Fecal Bile Acids as a Novel Early Indicator of Necrotizing Enterocolitis | Grant | 3,081,006.00 | Research | Melissa Halpern | Pediatrics | National Institute of Diabetes and Digestive and Kidney Diseases | 03/2024 |
* Award dollars are not included in the clinical trials, as funds are earned based upon completion of study milestones and enrollment.